Loading clinical trials...
Loading clinical trials...
Myotonic dystrophy type 1 (DM1) is one of the most common neuromuscular diseases in adults. As respiratory dysfunction is the most common cause of death in patients with DM1, a respiratory disease pro...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
CHU de Reims
NCT07486934 · Myotonic Dystrophy Type 1 (DM1), DM1, and more
NCT06809049 · Myotonic Dystrophy, Congenital, Myotonic Dystrophy, Type 1 (DM1), and more
NCT06708468 · Neuromuscular Diseases (NMD), Charcot Marie Tooth Disease (CMT), and more
NCT05072288 · Myotonic Dystrophy Type 1 (DM1)
NCT05027269 · DM1, Myotonic Dystrophy 1, and more
Chu Reims
Reims
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions